
Aka gatabo karambuye kerekana iterambere rigezweho muri kuvura genetique mutation ivura kanseri y'ibihaha. Twinjiye mubwoko butandukanye bwimiterere ihindagurika ijyanye na kanseri yibihaha, uburyo bwo kuvura buhari, hamwe nibintu byingenzi tugomba gusuzuma muguhitamo ibitaro kabuhariwe muri kano karere. Wige ibijyanye nubuvuzi bugenewe, immunotherapy, nubundi buryo bugezweho. Shakisha ibikoresho bigufasha kuyobora urugendo rwawe no gufata ibyemezo byuzuye.
Kanseri y'ibihaha ikunze guterwa no guhindagurika kwa genetike mu ngirabuzimafatizo. Kumenya ihinduka ry’imihindagurikire ni ngombwa mu kudoda neza. Guhinduka bisanzwe birimo EGFR, ALK, ROS1, BRAF, na KRAS. Kubaho kwa mutation yihariye bigira ingaruka kumahitamo yubuvuzi kandi bikavuga ko bishoboka ko hashobora kuvurwa imiti yihariye. Gusobanukirwa umwirondoro wawe wihariye nintambwe yambere mugutezimbere kugiti cyawe kuvura genetique mutation kuvura kanseri y'ibihaha gahunda. Kwipimisha genetike, nkisesengura rya biopsy, nibyingenzi kugirango tumenye.
Kubaho kwa mutation yihariye bigira ingaruka zikomeye kubyemezo byo kuvura. Kurugero, abarwayi bafite mutation ya EGFR barashobora kungukirwa na EGFR tyrosine kinase inhibitor (TKIs), mugihe abafite ihinduka rya ALK bashobora kwitabira neza ALK inhibitor. Ubuvuzi bugamije, bugamije kwibasira cyane kanseri ya kanseri ihindagurika, byahinduye u kuvura genetique mutation kuvura kanseri y'ibihaha ibibanza, bitanga ibisubizo byiza kandi bigabanya ingaruka ugereranije na chimiotherapie gakondo mubihe byinshi. Nyamara, imikorere iratandukanye bitewe na mutation yihariye nubuzima bwumurwayi muri rusange.
Ubuvuzi bugamije ni imiti igamije guhagarika ibikorwa bya poroteyine zihariye zigira uruhare mu mikurire ya kanseri. Iyi miti igira akamaro kanini kurwanya ihinduka ryimiterere yimiterere yimiterere yabantu, ikaba ibuye ryifatizo rya kijyambere kuvura genetique mutation kuvura kanseri y'ibihaha. Ingero zirimo EGFR TKIs (urugero, gefitinib, erlotinib, afatinib), inhibitor ya ALK (urugero, crizotinib, alectinib), hamwe na ROS1 inhibitor (urugero: crizotinib, entrectinib). Guhitamo imiti igamije guterwa ahanini na mutation yihariye yagaragaye.
Immunotherapy ikoresha imbaraga z'umubiri z'umubiri zo kurwanya kanseri. Ubu buvuzi buragenda bugira akamaro kanini mu kuvura kanseri y'ibihaha, harimo n'iyatewe n'imihindagurikire yihariye. Inzitizi za Checkpoint, nka pembrolizumab na nivolumab, ni ingero z'imiti ikingira indwara ikoreshwa mu kurekura ubushobozi bw'umubiri bwo kumenya no gusenya selile. Immunotherapy irashobora gukoreshwa wenyine cyangwa ifatanije nubundi buvuzi, harimo nubuvuzi bugamije, kubisubizo byiza muri kuvura genetique mutation kuvura kanseri y'ibihaha.
Chimiotherapie ikomeje kuba uburyo bwo kuvura kanseri y'ibihaha, nubwo ikoreshwa kenshi hamwe no kuvura cyangwa gukingira indwara. Guhitamo uburyo bwa chimiotherapie biterwa nibintu bitandukanye, harimo ubwoko bwa kanseri yibihaha, icyiciro cyindwara, nubuzima bwumurwayi muri rusange. Mugihe chimiotherapie ishobora kuba ingirakamaro, mubisanzwe ifitanye isano ningaruka nyinshi ugereranije nubuvuzi bugenewe hamwe nubudahangarwa.
Imiti ivura imirasire ikoresha imirasire yingufu nyinshi kugirango isenye kanseri. Irashobora gukoreshwa kugirango igabanye ibibyimba mbere yo kubagwa, kugabanya ibimenyetso, cyangwa gukuraho kanseri zisigaye nyuma yo kubagwa cyangwa ubundi buvuzi. Imiti ivura imirasire akenshi ni igice cyuburyo butandukanye bwo kuvura genetique mutation kuvura kanseri y'ibihaha.
Guhitamo ibitaro bifite ubuhanga bwo kuvura kanseri y'ibihaha ya geneti ihindagurika ni ingenzi ku musaruro mwiza. Suzuma ibi bintu:
Ibitaro byubushakashatsi bizwi muri gahunda za onkologiya no gushakisha abahanga muburyo bwo kuvura kanseri yihariye. Urashobora gusaba ibyifuzo byumuganga wawe wibanze cyangwa abandi bashinzwe ubuzima. Ku barwayi bashaka ubuvuzi bwuzuye, Shandong Baofa Ikigo Cyubushakashatsi Kanseri ni ikigo kiyobora gitanga ubuvuzi buhanitse nubushakashatsi muri oncology.
Uwiteka kuvura genetique mutation ivura kanseri y'ibihaha ibibanza bigenda bihindagurika, hamwe nubuvuzi bushya hamwe nuburyo bwo kuvura bugaragara buri gihe. Kumenya hakiri kare, gupima neza genetike, no guhitamo ibitaro bizwi hamwe nuburyo butandukanye nibyingenzi kugirango bigerweho neza. Aka gatabo ni intangiriro yo gusobanukirwa ningorabahizi zo kuvura kanseri y'ibihaha. Wibuke kugisha inama abashinzwe ubuzima kugirango bategure gahunda yihariye yo kuvura yujuje ibyo ukeneye.